Niagen Bioscience, Inc. (NAGE) Cash From Financing

Annual CFF:

$5.42M+$5.44M(+36240.00%)
December 31, 2024

Summary

  • As of today, NAGE annual cash from financing is $5.42 million, with the most recent change of +$5.44 million (+36240.00%) on December 31, 2024.
  • During the last 3 years, NAGE annual cash from financing has fallen by -$30.78 million (-85.03%).
  • NAGE annual cash from financing is now -88.94% below its all-time high of $49.02 million, reached on December 1, 2017.

Performance

NAGE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Quarterly CFF:

$148.00K-$3.60M(-96.05%)
September 30, 2025

Summary

  • As of today, NAGE quarterly cash from financing is $148.00 thousand, with the most recent change of -$3.60 million (-96.05%) on September 30, 2025.
  • Over the past year, NAGE quarterly cash from financing has dropped by -$891.00 thousand (-85.76%).
  • NAGE quarterly cash from financing is now -99.56% below its all-time high of $33.49 million, reached on March 1, 2021.

Performance

NAGE Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

TTM CFF:

$10.80M-$891.00K(-7.62%)
September 30, 2025

Summary

  • As of today, NAGE TTM cash from financing is $10.80 million, with the most recent change of -$891.00 thousand (-7.62%) on September 30, 2025.
  • Over the past year, NAGE TTM cash from financing has increased by +$9.17 million (+561.99%).
  • NAGE TTM cash from financing is now -77.98% below its all-time high of $49.02 million, reached on December 1, 2017.

Performance

NAGE TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NAGE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+10000.0%-85.8%+562.0%
3Y3 Years-85.0%+5033.3%+9207.8%
5Y5 Years-69.1%-69.9%+27.8%

NAGE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-85.0%>+9999.0%-98.1%+1580.0%-7.6%>+9999.0%
5Y5-Year-85.0%>+9999.0%-99.6%+1580.0%-74.4%>+9999.0%
All-TimeAll-Time-88.9%+7005.7%-99.6%+114.9%-78.0%+1122.3%

NAGE Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$148.00K(-96.1%)
$10.80M(-7.6%)
Jun 2025
-
$3.75M(+20.5%)
$11.69M(+36.9%)
Mar 2025
-
$3.11M(-17.9%)
$8.54M(+57.4%)
Dec 2024
$5.42M(>+9900.0%)
$3.79M(+264.7%)
$5.42M(+232.4%)
Sep 2024
-
$1.04M(+74.3%)
$1.63M(+176.9%)
Jun 2024
-
$596.00K(>+9900.0%)
$589.00K(+3564.7%)
Mar 2024
-
-$3000.00(-200.0%)
-$17.00K(-13.3%)
Dec 2023
-$15.00K(-100.2%)
-
-
Dec 2023
-
-$1000.00(+66.7%)
-$15.00K(-100.2%)
Sep 2023
-
-$3000.00(+70.0%)
$7.73M(0.0%)
Jun 2023
-
-$10.00K(-900.0%)
$7.73M(-0.1%)
Mar 2023
-
-$1000.00(-100.0%)
$7.73M(+0.0%)
Dec 2022
$7.73M(-78.6%)
$7.74M(>+9900.0%)
$7.73M(+6564.7%)
Sep 2022
-
-$3000.00(+25.0%)
$116.00K(-74.7%)
Jun 2022
-
-$4000.00(-33.3%)
$458.00K(-83.1%)
Mar 2022
-
-$3000.00(-102.4%)
$2.71M(-92.5%)
Dec 2021
$36.20M(+316.2%)
$126.00K(-62.8%)
$36.20M(-2.9%)
Sep 2021
-
$339.00K(-84.9%)
$37.28M(-0.4%)
Jun 2021
-
$2.25M(-93.3%)
$37.43M(-11.2%)
Mar 2021
-
$33.49M(+2690.8%)
$42.14M(+384.4%)
Dec 2020
$8.70M(-50.5%)
$1.20M(+143.9%)
$8.70M(+3.0%)
Sep 2020
-
$492.00K(-92.9%)
$8.45M(-43.6%)
Jun 2020
-
$6.96M(>+9900.0%)
$14.99M(-14.6%)
Mar 2020
-
$52.00K(-94.5%)
$17.56M(-0.0%)
Dec 2019
$17.56M(>+9900.0%)
$949.00K(-86.5%)
$17.56M(+5.9%)
Sep 2019
-
$7.04M(-26.1%)
$16.59M(+71.1%)
Jun 2019
-
$9.52M(>+9900.0%)
$9.70M(+5286.7%)
Mar 2019
-
$55.00K(+329.2%)
$180.00K(+353.5%)
Dec 2018
-$71.00K(-100.1%)
-$24.00K(-116.9%)
-$71.00K(-100.3%)
Sep 2018
-
$142.00K(+1928.6%)
$25.43M(-16.1%)
Jun 2018
-
$7000.00(+103.6%)
$30.30M(-38.0%)
Mar 2018
-
-$196.00K(-100.8%)
$48.89M(-0.3%)
Dec 2017
$49.02M(+5165.1%)
$25.48M(+408.7%)
$49.02M(+108.7%)
Sep 2017
-
$5.01M(-73.1%)
$23.49M(+28.8%)
Jun 2017
-
$18.60M(>+9900.0%)
$18.23M(+3564.6%)
Mar 2017
-
-$60.00K(-4.0%)
$497.60K(-46.6%)
Dec 2016
$931.10K
-$57.70K(+76.5%)
$931.10K(-68.8%)
Sep 2016
-
-$245.30K(-128.5%)
$2.98M(-6.4%)
DateAnnualQuarterlyTTM
Jun 2016
-
$860.60K(+130.4%)
$3.18M(-33.3%)
Mar 2016
-
$373.50K(-81.3%)
$4.77M(+9.9%)
Dec 2015
$4.34M(+61.3%)
$1.99M(+4888.7%)
$4.34M(-7.9%)
Sep 2015
-
-$41.60K(-101.7%)
$4.72M(-7.8%)
Jun 2015
-
$2.45M(+4391.4%)
$5.12M(+93.7%)
Mar 2015
-
-$57.10K(-102.4%)
$2.64M(-1.9%)
Dec 2014
$2.69M(-42.1%)
$2.37M(+558.0%)
$2.69M(-17.7%)
Sep 2014
-
$359.70K(+1442.2%)
$3.27M(+13.1%)
Jun 2014
-
-$26.80K(-332.3%)
$2.89M(-26.6%)
Mar 2014
-
-$6200.00(-100.2%)
$3.94M(-15.2%)
Dec 2013
$4.65M(-54.8%)
$2.95M(>+9900.0%)
$4.65M(+166.3%)
Sep 2013
-
-$19.60K(-101.9%)
$1.75M(-6.1%)
Jun 2013
-
$1.02M(+46.0%)
$1.86M(+96.1%)
Mar 2013
-
$699.80K(+1505.0%)
$948.00K(-90.8%)
Dec 2012
$10.30M(+317.0%)
$43.60K(-53.6%)
$10.30M(+0.7%)
Sep 2012
-
$93.90K(-15.2%)
$10.23M(-12.1%)
Jun 2012
-
$110.70K(-98.9%)
$11.63M(-3.4%)
Mar 2012
-
$10.05M(>+9900.0%)
$12.04M(+387.5%)
Dec 2011
$2.47M(-46.5%)
-$23.80K(-101.6%)
$2.47M(-5.9%)
Sep 2011
-
$1.50M(+190.1%)
$2.63M(+134.0%)
Jun 2011
-
$515.80K(+7.3%)
$1.12M(-78.0%)
Mar 2011
-
$480.70K(+264.2%)
$5.11M(+10.6%)
Dec 2010
$4.62M(+5980.0%)
$132.00K(+2013.0%)
$4.62M(+3.3%)
Sep 2010
-
-$6900.00(-100.2%)
$4.47M(+0.3%)
Jun 2010
-
$4.50M(>+9900.0%)
$4.45M(+6572.5%)
Mar 2010
-
-$10.50K(+34.8%)
-$68.80K(+12.2%)
Dec 2009
-$78.50K(-102.4%)
-$16.10K(+24.8%)
-$78.40K(+92.6%)
Sep 2009
-
-$21.40K(-2.9%)
-$1.06M(-1524.8%)
Jun 2009
-
-$20.80K(-3.5%)
-$65.00K(-102.0%)
Mar 2009
-
-$20.10K(+98.0%)
$3.22M(-0.6%)
Dec 2008
$3.24M(>+9900.0%)
-$993.80K(-202.5%)
$3.24M(-23.5%)
Sep 2008
-
$969.70K(-70.3%)
$4.23M(+29.7%)
Jun 2008
-
$3.26M(>+9900.0%)
$3.26M(>+9900.0%)
Feb 2008
-
$0.00(0.0%)
$900.00(0.0%)
Nov 2007
$900.00(-97.7%)
$0.00(0.0%)
$900.00(0.0%)
Aug 2007
-
$0.00(-100.0%)
$900.00(0.0%)
May 2007
-
$900.00(>+9900.0%)
$900.00(>+9900.0%)
Feb 2007
-
$0.00
$0.00
Nov 2006
$39.10K
-
-

FAQ

  • What is Niagen Bioscience, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual cash from financing year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly cash from financing year-on-year change?
  • What is Niagen Bioscience, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. TTM cash from financing year-on-year change?

What is Niagen Bioscience, Inc. annual cash from financing?

The current annual cash from financing of NAGE is $5.42M

What is the all-time high annual cash from financing for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual cash from financing is $49.02M

What is Niagen Bioscience, Inc. annual cash from financing year-on-year change?

Over the past year, NAGE annual cash from financing has changed by +$5.44M (+36240.00%)

What is Niagen Bioscience, Inc. quarterly cash from financing?

The current quarterly cash from financing of NAGE is $148.00K

What is the all-time high quarterly cash from financing for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly cash from financing is $33.49M

What is Niagen Bioscience, Inc. quarterly cash from financing year-on-year change?

Over the past year, NAGE quarterly cash from financing has changed by -$891.00K (-85.76%)

What is Niagen Bioscience, Inc. TTM cash from financing?

The current TTM cash from financing of NAGE is $10.80M

What is the all-time high TTM cash from financing for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high TTM cash from financing is $49.02M

What is Niagen Bioscience, Inc. TTM cash from financing year-on-year change?

Over the past year, NAGE TTM cash from financing has changed by +$9.17M (+561.99%)
On this page